# Metabolomics Evaluation of the Age-Related Eye Disease Study (AREDS)

Canonical: https://abierto.us/opportunities/75n98024p01214

- Solicitation number: 75N98024P01214
- Notice type: Special notice
- Status: Awarded to Metabolon, Inc.
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health (n-NATIONALINSTITUTESOFHEALTH)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: B529 Scientific Data Studies
- Place of performance: Morrisville, North Carolina
- County: Wake County (FIPS 37183). https://abierto.us/counties/wake-county-nc-37183
- City: Morrisville. https://abierto.us/cities/morrisville-nc-3744520
- First posted: March 14, 2024
- Last posted: March 14, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/0f2cd3c6341a41b8b474c2d9091a83f7/view

## Description

The National Institutes of Health, Office of Logistics and Acquisition Operations (OLAO), Office of Acquisitions (OA), on behalf of the National Eye Institute (NEI) intends to solicit a fixed price contract via FAR 13.5 with Metabolon, Inc., to perform a non-targeted metabolomics evaluation of participants aged 55 and older who were enrolled in the randomized controlled clinical trial Age-Related Eye Disease Study 2 (AREDS2 [2006 to 2012]) with varying severity of age-related macular degeneration (AMD) at baseline and followed longitudinally.

Approximately 1,897 samples will be evaluated. This is a follow-on to the pilot study 75N98021P02397 conducted by Metabolon, Inc. The anticipated period of performance is 12 months from date of award.

**NAICS:** 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

**Authority:** FAR 13.5. This Notice is not a request for proposals, proposal abstracts, or quotations and does not commit the Government to any contractual agreement. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. Statement of Work is attached to this notice.

## Award on USAspending

- Recipient: Metabolon, Inc. (UEI SBY5A7EK9PU3)
- Contract: 75N98024P01214, purchase order
- Obligated: $484,401.20
- Competition: Not Competed Under SAP, 1 offers received
- Link: solicitation number 75N98024P01214 equals the FPDS solicitation identifier; same sub-agency 7529 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75N98024P01214_7529_-NONE-_-NONE-/


## Publications

- March 14, 2024: Special notice, due March 25, 2024 at 12:00 PM EDT. Notice 0f2cd3c6341a41b8b474c2d9091a83f7. https://sam.gov/workspace/contract/opp/0f2cd3c6341a41b8b474c2d9091a83f7/view

## Points of contact

- Louis Kuta Sr, LOUIS.KUTA@NIH.GOV, (301) 594-5782

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n98024p01214.